Core Viewpoint - Midland States Bancorp (MSBI) reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.52 per share, and showing an increase from $0.53 per share a year ago, representing an earnings surprise of 9.62% [1][2] Financial Performance - The company posted revenues of $75.95 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.40%, although this is a decrease from $77.11 million in the same quarter last year [2] - Over the last four quarters, Midland States Bancorp has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Midland States Bancorp shares have declined approximately 32.5% since the beginning of the year, compared to a decline of 5.5% for the S&P 500 [3] - The current Zacks Rank for the stock is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.64 on revenues of $73.95 million, and for the current fiscal year, it is $2.52 on revenues of $296.8 million [7] - The trend of estimate revisions for Midland States Bancorp has been unfavorable ahead of the earnings release [6] Industry Context - The Zacks Industry Rank for Banks - Northeast, to which Midland States Bancorp belongs, is currently in the top 25% of over 250 Zacks industries, suggesting a favorable industry outlook [8]

分组1 - Ionis Pharmaceuticals reported a quarterly loss of $0.75 per share, better than the Zacks Consensus Estimate of a loss of $1.11, and improved from a loss of $0.98 per share a year ago, representing an earnings surprise of 32.43% [1] - The company posted revenues of $132 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 9.86%, and compared to year-ago revenues of $119 million [2] - Ionis Pharmaceuticals has surpassed consensus EPS estimates for four consecutive quarters [2] 分组2 - The stock has underperformed the market, losing about 14.7% since the beginning of the year, while the S&P 500 declined by 5.5% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.85 on revenues of $146.33 million, and for the current fiscal year, it is -$3.31 on revenues of $637.57 million [7] - The Zacks Industry Rank for Medical - Drugs is in the top 20% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Company Performance - Polaris Inc reported a quarterly loss of $0.90 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.91, compared to earnings of $0.23 per share a year ago, indicating an earnings surprise of 1.10% [1] - The company posted revenues of $1.54 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.67%, but down from $1.74 billion in the same quarter last year [2] - Over the last four quarters, Polaris has exceeded consensus EPS estimates two times and topped revenue estimates twice [2] Stock Performance - Polaris Inc shares have declined approximately 41.4% since the beginning of the year, contrasting with the S&P 500's decline of 6% [3] - The current Zacks Rank for Polaris Inc is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.63 on revenues of $1.83 billion, and for the current fiscal year, it is also $0.63 on revenues of $6.83 billion [7] - The outlook for the Automotive - Domestic industry, to which Polaris belongs, is currently in the bottom 19% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Viewpoint - Portland General Electric (POR) reported quarterly earnings of $0.91 per share, missing the Zacks Consensus Estimate of $0.93 per share, and down from $1.21 per share a year ago, indicating a -2.15% earnings surprise [1] Financial Performance - The company posted revenues of $928 million for the quarter ended March 2025, which was 0.41% below the Zacks Consensus Estimate and slightly down from $929 million year-over-year [2] - Over the last four quarters, Portland General Electric has surpassed consensus EPS estimates three times and topped revenue estimates three times as well [2] Stock Performance - Since the beginning of the year, Portland General Electric shares have declined approximately 1.5%, outperforming the S&P 500's decline of 6.8% [3] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.64 on revenues of $767.66 million, and for the current fiscal year, it is $3.21 on revenues of $3.6 billion [7] - The estimate revisions trend for Portland General Electric is mixed, and future revisions may change following the recent earnings report [6] Industry Context - The Utility - Electric Power industry is currently in the top 15% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]